Medical device maker Stryker to buy Wright Medical for $4 billion

(Reuters) – Medical device maker Stryker Corp (N:) said on Monday it would buy smaller rival Wright Medical Group (O:) for about $4 billion in cash, to strengthen its upper-body joint implants business.

The deal for $30.75 per share of Wright represents a premium of 39.7% to the company’s close on Friday.

Shares of Wright Medical rose 31% to $28.85 in premarket trading.

Including debt, the deal values Wright at about $5.4 billion and is expected to close in the second half of 2020.

Wright Medical is among the top makers of implants to treat upper-body joint injuries in areas such as the shoulder and wrist as well as lower body including the foot and ankle.

Bloomberg reported on Friday that Wright Medical was working with financial advisers and was exploring a potential sale.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.